Cargando…
Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women
Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival pro...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071365/ https://www.ncbi.nlm.nih.gov/pubmed/35530311 http://dx.doi.org/10.3389/fonc.2022.845527 |
_version_ | 1784700831383158784 |
---|---|
author | de Almeida, Liz Maria Cortés, Sandra Vilensky, Marta Valenzuela, Olivia Cortes-Sanabria, Laura de Souza, Mirian Barbeito, Rafael Alonso Abdelhay, Eliana Artagaveytia, Nora Daneri-Navarro, Adrian Llera, Andrea S. Müller, Bettina Podhajcer, Osvaldo L. Velazquez, Carlos Alcoba, Elsa Alonso, Isabel Bravo, Alicia I. Camejo, Natalia Carraro, Dirce Maria Castro, Mónica Cataldi, Sandra Cayota, Alfonso Cerda, Mauricio Colombo, Alicia Crocamo, Susanne Del Toro-Arreola, Alicia Delgadillo-Cristerna, Raul Delgado, Lucia Breitenbach, Marisa Dreyer Fernández, Elmer Fernández, Jorge Fernández, Wanda Franco-Topete, Ramon A. Gaete, Fancy Gómez, Jorge Gonzalez-Ramirez, Leivy P. Guerrero, Marisol Gutierrez-Rubio, Susan A. Jalfin, Beatriz Lopez-Vazquez, Alejandra Loria, Dora Míguez, Silvia Moran-Mendoza, Andres de J. Morgan-Villela, Gilberto Mussetti, Carina Nagai, Maria Aparecida Oceguera-Villanueva, Antonio Reis, Rui M. Retamales, Javier Rodriguez, Robinson Rosales, Cristina Salas-Gonzalez, Efrain Segovia, Laura Sendoya, Juan M. Silva-Garcia, Aida A. Viña, Stella Zagame, Livia Jones, Beth Szklo, Moysés |
author_facet | de Almeida, Liz Maria Cortés, Sandra Vilensky, Marta Valenzuela, Olivia Cortes-Sanabria, Laura de Souza, Mirian Barbeito, Rafael Alonso Abdelhay, Eliana Artagaveytia, Nora Daneri-Navarro, Adrian Llera, Andrea S. Müller, Bettina Podhajcer, Osvaldo L. Velazquez, Carlos Alcoba, Elsa Alonso, Isabel Bravo, Alicia I. Camejo, Natalia Carraro, Dirce Maria Castro, Mónica Cataldi, Sandra Cayota, Alfonso Cerda, Mauricio Colombo, Alicia Crocamo, Susanne Del Toro-Arreola, Alicia Delgadillo-Cristerna, Raul Delgado, Lucia Breitenbach, Marisa Dreyer Fernández, Elmer Fernández, Jorge Fernández, Wanda Franco-Topete, Ramon A. Gaete, Fancy Gómez, Jorge Gonzalez-Ramirez, Leivy P. Guerrero, Marisol Gutierrez-Rubio, Susan A. Jalfin, Beatriz Lopez-Vazquez, Alejandra Loria, Dora Míguez, Silvia Moran-Mendoza, Andres de J. Morgan-Villela, Gilberto Mussetti, Carina Nagai, Maria Aparecida Oceguera-Villanueva, Antonio Reis, Rui M. Retamales, Javier Rodriguez, Robinson Rosales, Cristina Salas-Gonzalez, Efrain Segovia, Laura Sendoya, Juan M. Silva-Garcia, Aida A. Viña, Stella Zagame, Livia Jones, Beth Szklo, Moysés |
author_sort | de Almeida, Liz Maria |
collection | PubMed |
description | Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival probabilities (OS) were estimated. From 2011 to 2013, 1,300 eligible Latin-American women 18 years or older, with a diagnosis of breast cancer in clinical stage II or III, and performance status ≦̸1 were invited to participate in a prospective cohort study. Face-to-face interviews were conducted, and clinical and outcome data, including death, were extracted from medical records. Unadjusted associations were evaluated by Chi-squared and Fisher’s exact tests and the OS by Kaplan–Meier method. Log-rank test was used to determine differences between cumulative probability curves. Multivariable adjustment was carried out by entering potential confounders in the Cox regression model. The OS at 60 months was 83.9%. Multivariable-adjusted death hazard differences were found for women living in Argentina (2.27), Chile (1.95), and Uruguay (2.42) compared with Mexican women, for older (≥60 years) (1.84) compared with younger (≤40 years) women, for basal-like subtype (5.8), luminal B (2.43), and HER2-enriched (2.52) compared with luminal A subtype, and for tumor clinical stages IIB (1.91), IIIA (3.54), and IIIB (3.94) compared with stage IIA women. OS was associated with country of residence, PAM50 intrinsic subtype, age, and tumor stage at diagnosis. While the latter is known to be influenced by access to care, including cancer screening, timely diagnosis and treatment, including access to more effective treatment protocols, it may also influence epigenetic changes that, potentially, impact molecular subtypes. Data derived from heretofore understudied populations with unique geographic ancestry and sociocultural experiences are critical to furthering our understanding of this complexity. |
format | Online Article Text |
id | pubmed-9071365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90713652022-05-06 Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women de Almeida, Liz Maria Cortés, Sandra Vilensky, Marta Valenzuela, Olivia Cortes-Sanabria, Laura de Souza, Mirian Barbeito, Rafael Alonso Abdelhay, Eliana Artagaveytia, Nora Daneri-Navarro, Adrian Llera, Andrea S. Müller, Bettina Podhajcer, Osvaldo L. Velazquez, Carlos Alcoba, Elsa Alonso, Isabel Bravo, Alicia I. Camejo, Natalia Carraro, Dirce Maria Castro, Mónica Cataldi, Sandra Cayota, Alfonso Cerda, Mauricio Colombo, Alicia Crocamo, Susanne Del Toro-Arreola, Alicia Delgadillo-Cristerna, Raul Delgado, Lucia Breitenbach, Marisa Dreyer Fernández, Elmer Fernández, Jorge Fernández, Wanda Franco-Topete, Ramon A. Gaete, Fancy Gómez, Jorge Gonzalez-Ramirez, Leivy P. Guerrero, Marisol Gutierrez-Rubio, Susan A. Jalfin, Beatriz Lopez-Vazquez, Alejandra Loria, Dora Míguez, Silvia Moran-Mendoza, Andres de J. Morgan-Villela, Gilberto Mussetti, Carina Nagai, Maria Aparecida Oceguera-Villanueva, Antonio Reis, Rui M. Retamales, Javier Rodriguez, Robinson Rosales, Cristina Salas-Gonzalez, Efrain Segovia, Laura Sendoya, Juan M. Silva-Garcia, Aida A. Viña, Stella Zagame, Livia Jones, Beth Szklo, Moysés Front Oncol Oncology Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival probabilities (OS) were estimated. From 2011 to 2013, 1,300 eligible Latin-American women 18 years or older, with a diagnosis of breast cancer in clinical stage II or III, and performance status ≦̸1 were invited to participate in a prospective cohort study. Face-to-face interviews were conducted, and clinical and outcome data, including death, were extracted from medical records. Unadjusted associations were evaluated by Chi-squared and Fisher’s exact tests and the OS by Kaplan–Meier method. Log-rank test was used to determine differences between cumulative probability curves. Multivariable adjustment was carried out by entering potential confounders in the Cox regression model. The OS at 60 months was 83.9%. Multivariable-adjusted death hazard differences were found for women living in Argentina (2.27), Chile (1.95), and Uruguay (2.42) compared with Mexican women, for older (≥60 years) (1.84) compared with younger (≤40 years) women, for basal-like subtype (5.8), luminal B (2.43), and HER2-enriched (2.52) compared with luminal A subtype, and for tumor clinical stages IIB (1.91), IIIA (3.54), and IIIB (3.94) compared with stage IIA women. OS was associated with country of residence, PAM50 intrinsic subtype, age, and tumor stage at diagnosis. While the latter is known to be influenced by access to care, including cancer screening, timely diagnosis and treatment, including access to more effective treatment protocols, it may also influence epigenetic changes that, potentially, impact molecular subtypes. Data derived from heretofore understudied populations with unique geographic ancestry and sociocultural experiences are critical to furthering our understanding of this complexity. Frontiers Media S.A. 2022-03-08 /pmc/articles/PMC9071365/ /pubmed/35530311 http://dx.doi.org/10.3389/fonc.2022.845527 Text en Copyright © 2022 de Almeida, Cortés, Vilensky, Valenzuela, Cortes-Sanabria, de Souza, Barbeito, Abdelhay, Artagaveytia, Daneri-Navarro, Llera, Müller, Podhajcer, Velazquez, Alcoba, Alonso, Bravo, Camejo, Carraro, Castro, Cataldi, Cayota, Cerda, Colombo, Crocamo, Del Toro-Arreola, Delgadillo-Cristerna, Delgado, Breitenbach, Fernández, Fernández, Fernández, Franco-Topete, Gaete, Gómez, Gonzalez-Ramirez, Guerrero, Gutierrez-Rubio, Jalfin, Lopez-Vazquez, Loria, Míguez, Moran-Mendoza, Morgan-Villela, Mussetti, Nagai, Oceguera-Villanueva, Reis, Retamales, Rodriguez, Rosales, Salas-Gonzalez, Segovia, Sendoya, Silva-Garcia, Viña, Zagame, Jones, Szklo and United States-Latin American Cancer Research Network (US-LACRN) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology de Almeida, Liz Maria Cortés, Sandra Vilensky, Marta Valenzuela, Olivia Cortes-Sanabria, Laura de Souza, Mirian Barbeito, Rafael Alonso Abdelhay, Eliana Artagaveytia, Nora Daneri-Navarro, Adrian Llera, Andrea S. Müller, Bettina Podhajcer, Osvaldo L. Velazquez, Carlos Alcoba, Elsa Alonso, Isabel Bravo, Alicia I. Camejo, Natalia Carraro, Dirce Maria Castro, Mónica Cataldi, Sandra Cayota, Alfonso Cerda, Mauricio Colombo, Alicia Crocamo, Susanne Del Toro-Arreola, Alicia Delgadillo-Cristerna, Raul Delgado, Lucia Breitenbach, Marisa Dreyer Fernández, Elmer Fernández, Jorge Fernández, Wanda Franco-Topete, Ramon A. Gaete, Fancy Gómez, Jorge Gonzalez-Ramirez, Leivy P. Guerrero, Marisol Gutierrez-Rubio, Susan A. Jalfin, Beatriz Lopez-Vazquez, Alejandra Loria, Dora Míguez, Silvia Moran-Mendoza, Andres de J. Morgan-Villela, Gilberto Mussetti, Carina Nagai, Maria Aparecida Oceguera-Villanueva, Antonio Reis, Rui M. Retamales, Javier Rodriguez, Robinson Rosales, Cristina Salas-Gonzalez, Efrain Segovia, Laura Sendoya, Juan M. Silva-Garcia, Aida A. Viña, Stella Zagame, Livia Jones, Beth Szklo, Moysés Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women |
title | Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women |
title_full | Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women |
title_fullStr | Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women |
title_full_unstemmed | Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women |
title_short | Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women |
title_sort | socioeconomic, clinical, and molecular features of breast cancer influence overall survival of latin american women |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071365/ https://www.ncbi.nlm.nih.gov/pubmed/35530311 http://dx.doi.org/10.3389/fonc.2022.845527 |
work_keys_str_mv | AT dealmeidalizmaria socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT cortessandra socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT vilenskymarta socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT valenzuelaolivia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT cortessanabrialaura socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT desouzamirian socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT barbeitorafaelalonso socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT abdelhayeliana socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT artagaveytianora socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT danerinavarroadrian socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT lleraandreas socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT mullerbettina socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT podhajcerosvaldol socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT velazquezcarlos socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT alcobaelsa socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT alonsoisabel socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT bravoaliciai socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT camejonatalia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT carrarodircemaria socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT castromonica socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT cataldisandra socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT cayotaalfonso socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT cerdamauricio socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT colomboalicia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT crocamosusanne socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT deltoroarreolaalicia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT delgadillocristernaraul socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT delgadolucia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT breitenbachmarisadreyer socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT fernandezelmer socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT fernandezjorge socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT fernandezwanda socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT francotopeteramona socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT gaetefancy socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT gomezjorge socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT gonzalezramirezleivyp socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT guerreromarisol socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT gutierrezrubiosusana socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT jalfinbeatriz socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT lopezvazquezalejandra socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT loriadora socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT miguezsilvia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT moranmendozaandresdej socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT morganvillelagilberto socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT mussetticarina socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT nagaimariaaparecida socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT ocegueravillanuevaantonio socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT reisruim socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT retamalesjavier socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT rodriguezrobinson socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT rosalescristina socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT salasgonzalezefrain socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT segovialaura socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT sendoyajuanm socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT silvagarciaaidaa socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT vinastella socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT zagamelivia socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT jonesbeth socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT szklomoyses socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen AT socioeconomicclinicalandmolecularfeaturesofbreastcancerinfluenceoverallsurvivaloflatinamericanwomen |